Asia-Pacific cell line development market revenue is expected to register a 13% CAGR during 2020 to 2026, driven by the presence of a large patient pool suffering from various chronic and infectious diseases. Growing investments in stem cell research, coupled with surge in demand for regenerative medicine, will also favor the regional industry growth.

Culmen expands analytics and big data discovery technology with acquisition

The MSP Centrifuge has partnered with Vernon Southmayd, the developer of App-Care, an innovative and cutting edge software application that integrates with LabTech (RMM Tool) and automatically updates vital third party applications.